ARAY Stock Falls Despite Positive Data of CyberKnife in Treating BSM

Accuray Incorporated (ARAY) recently revealed findings from an international multicenter analysis, showing that the CyberKnife System delivers effective and time-efficient treatment for brainstem metastases (“BSM”). The study highlights stereotactic radiosurgery (“SRS”) and fractionated stereotactic radiotherapy (“FSRT”) as achievers of long-term local control with a strong safety profile, even in sensitive brain regions.The brainstem is an integral part of the central nervous system and metastatic spread t ...